CRL
Charles River Laboratories International, Inc. · Healthcare
EVP, Corp Strategy, Develop Joseph W Laplume sold $296K of Charles River Laboratories International, Inc.
Sold$295,969
$226.97Price
1,304Shares
−5%Stake
What CRL did after the filing
- The stock from Tue, May 14 close, $232.82
- −10.9%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 27 close.
Traded Fri, May 10. Filed Tue, May 14, 12:49 PM ET, during the session. Returns use the May 14 close and the Jun 27 close. Not investment advice.